Skip to main content
. 2023 May 19;30(8):4840–4851. doi: 10.1245/s10434-023-13372-z

Table 1.

Characteristics of patients who underwent hepatectomy for neuroendocrine tumor liver metastasesa

All patients (n = 546) Small intestine (n = 279) Pancreas (n = 194) Other sites (n = 73) p Value
n (%) n (%) n (%) n (%)
Median age: years (IQR) 59 (50–66) 61 (53–69) 57 (48–64) 55 (48–65) < 0.001
Sex
 Male 280 (51) 143 (51) 104 (54) 33 (45) 0.47
 Female 266 (49) 136 (49) 90 (46) 40 (55)
Functional tumor
 No 345 (63) 130 (47) 161 (83) 54 (74) < 0.001
 Yes 201 (37) 149 (53) 33 (17) 19 (26)
Ki-67 index (%)b
 < 3 69 (29) 50 (44) 12 (13) 7 (26) < 0.001
 3–20 125 (53) 53 (46) 59 (63) 13 (48)
 > 20 41 (17) 12 (10) 22 (24) 7 (26)
No. of liver lesions
 1–3 138 (25) 62 (22) 51 (26) 25 (34) 0.030
 4–9 126 (23) 56 (20) 50 (26) 20 (27)
 ≥ 10 282 (52) 161 (58) 93 (48) 28 (38)
Size of largest lesion
 Median: mm (IQR) 42 (21–70) 40 (20–70) 38 (20–65) 58 (30–87) 0.028
Extrahepatic distant metastases
 No 456 (84) 211 (76) 179 (92) 66 (90) < 0.001
 Yes 90 (16) 68 (24) 15 (7.7) 7 (9.6)
Extent of cytoreduction
 Complete cytoreduction 410 (75) 209 (75) 146 (75) 55 (75) 0.95
 Incomplete debulking (> 90%) 110 (20) 56 (20) 38 (20) 16 (22)
 Incomplete debulking (< 90%) 26 (4.8) 14 (5.0) 10 (5.2) 2 (2.7)

IQR, interquartile range

aCategorical variables are presented as number (%) and continuous variables as median (IQR)

bPatients with missing Ki-67 values (n = 307) were excluded from the respective univariate analysis